Mesothelin-targeting CAR T cells and NK cells show robust anti-tumor efficacy against cancers in human xenograft models, such as TNBC, pancreatic, malignant pleural mesothelioma, ovarian, and GC. This evidence concerns the gene MSLN and cancer.